Combined Therapeutics
Maxime Lesieur possesses a diverse background in finance and education, having worked as a Fundraiser and Investor at Combined Therapeutics and as an Investment Banking Analyst at Degroof Petercam. Prior experience includes serving as a Junior Auditor at EY and as an Oral Examinator in Economics, Sociology, and History of the Contemporary World at Académie de Paris. This combination of roles highlights Maxime Lesieur's expertise in both analytical finance and academic assessment.
This person is not in any teams
This person is not in any offices
Combined Therapeutics
CTx is preclinical biotech developing the second generation of therapeutic & intelligent mRNA.